25-hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus

Rheumatology

Volumn 51, Issue 3, 2012, Pages 544-551

  Reynolds, John A ^a   Haque, Sahena ^a   Berry, Jacqueline L ^a   Pemberton, Philip ^b   Teh, Lee Suan ^c   Ho, Pauline ^d   Gorodkin, Rachel ^d   Bruce, Ian N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiovascular risk; Disease activity; Systemic lupus erythematosus; Vascular stiffness; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN;

ADULT; AORTIC PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PULSE WAVE; SCORING SYSTEM; SLEDAI 2K SCORE; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84857543005     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker352     Document Type: Article

References (54)

1. Urowitz MB, Bookman AAM, Koehler BE et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
2. Bruce IN, Urowitz MB, Gladman DD et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 2003;48:3159-67.
3. Esdaile JM, Abrahamowicz M, Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
4. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
5. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266-81.
6. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010;39:365-79, table.
7. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D Levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9.
8. Scragg R, Jackson R, Holdaway IM et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990;19:559-63.
9. Wang TJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
10. Doherty TM, Tang W, Dascalos S et al. Ethnic origin and serum levels of 1{alpha},25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 1997;96:1477-81.
11. Jablonski KL, Chonchol M, Pierce GL et al. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011;57: 63-9.
12. Pilz S, Henry R, Snijder M et al. 25-Hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women. Calcif Tissue Int 2009;84:423-4.
13. Reis JP, von Muhlen D, Michos ED et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 2009;207:589-90.
14. Tarcin O, Yavuz DG, Ozben B et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94: 4023-30.
15. Watson KE, Abrolat ML, Malone LL et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-60.
16. Damanhouri LH. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 2009;30: 1291-5.
17. Kamen DL, Cooper GS, Bouali H et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114-7.
18. Borba V, Vieira J, Kasamatsu T et al. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009;20:427-33.
19. Muller K, Kriegbaum NJ, Baslund B et al. Vitamin-D-3 Metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D-3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995;14: 397-400.
20. Amital H, Szekanecz Z, Szucs G et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010;69: 1155-7.
21. Broder A, Tobin J, Putterman C. Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Res Ther 2010;12: R191.
22. Ruiz-Irastorza G, Egurbide MV, Olivares N et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 2008;47:920-3.
23. Klein RG, Arnaud SB, Gallagher JC et al. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977;60:253-9.
24. Reynolds JA, Bruce IN. Vitamin D in systemic lupus erythematosus: potential beyond bone health. Int J Clin Rheum 2009;4:297-309.
25. Szodoray P, Tarr T, Bazso A et al. The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol 2010;1-5.
26. Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008;17:6-10.
27. Orbach H, Zandman-Goddard G, Amital H et al. Novel biomarkers in autoimmune diseases. Ann N Y Acad Sci 2007;1109:385-400.
28. Chen S, Sims GP, Chen XX et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634-47.
29. Lopez-Robles C, Rios-Fernandez R, Callejas-Rubio J et al. Vitamin D deficiency in a cohort of patients with systemic lupus erythematous in the South of Spain. Lupus 2011; 330-1.
30. Kim HA, Sung JM, Jeon JY et al. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int 2011;31: 1189-94.
31. Toloza SMA, Cole DEC, Gladman DD et al. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19: 13-9.
32. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
33. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
34. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
35. Asmar R, Benetos A, Topouchian J et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995;26:485-90.
36. Sidhu PS, Desai SR. A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol 1997;70:85-9.
37. Li R, Duncan BB, Metcalf PA et al. B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 1994;25:2377-83.
38. Wu PW, Rhew EY, Dyer AR et al. 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Care Res 2009;61:1387-95.
39. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
40. Angel K, Provan SA, Gulseth HL et al. Tumor necrosis factor-{alpha} antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 2010;55:333-8.
41. Selzer F, Sutton-Tyrrell K, Fitzgerald S et al. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001;37:1075-82.
42. Jeffery LE, Burke F, Mura M et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009;183:5458-67.
43. Boonstra A, Barrat FJ, Crain C et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001;167: 4974-80.
44. Overbergh L, Decallonne B, Waer M et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000;49:1301-7.
45. Linker-Israeli M, Elstner E, Klinenberg JR et al. Vitamin D3 and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001;99:82-93.
46. Vilarrasa N, Maravall J, Estepa A et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007;30:653-8.
47. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W et al. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009;36: 205-10.
48. Gannage-Yared MH, Chedid R, Khalife S et al. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009;160:965-71.
49. Studenski S, Allen NB, Caldwell DS et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987;30: 1326-32.
50. Alarcon GS, Roseman J, Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum 1998;41:1173-80.
51. Lowe NM, Mitra SR, Foster PC et al. Vitamin D status and markers of bone turnover in Caucasian and South Asian postmenopausal women living in the UK. Br J Nutr 2010; 103:1706-10.
52. Ford L, Graham V, Wall A et al. Vitamin D concentrations in an UK inner-city multicultural outpatient population. Ann Clin Biochem 2006;43:468-73.
53. Thompson T, Sutton-Tyrell K, Wilman RP et al. Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 2008;58:835-42.
54. Sabio JM, Vargas-Hitos J, Zamora-Pasadas M et al. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. J Rheumatol 2009;36:2204-11.